| Basics |
TherapeuticsMD, Inc.
TherapeuticsMD Inc is a women's health care company focused on creating and commercializing products targeted exclusively for women. It is engaged in pre-commercialization activities for advanced hormone therapy pharmaceutical product.
|
| IPO Date: |
October 31, 2011 |
| Sector: |
Healthcare |
| Industry: |
Pharma |
| Market Cap: |
$12.5M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.12 | 3.21%
|
| Avg Daily Range (30 D): |
$0.02 | 1.89%
|
| Avg Daily Range (90 D): |
$0.04 | 2.95%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
2.24M |
| Avg Daily Volume (30 D): |
.02M |
| Avg Daily Volume (90 D): |
.03M |
| Trade Size |
| Avg Trade Size (Sh.): |
288 |
| Avg Trade Size (Sh.) (30 D): |
181 |
| Avg Trade Size (Sh.) (90 D): |
194 |
| Institutional Trades |
| Total Inst.Trades: |
1,122 |
| Avg Inst. Trade: |
$1.43M |
| Avg Inst. Trade (30 D): |
$2.37M |
| Avg Inst. Trade (90 D): |
$2.37M |
| Avg Inst. Trade Volume: |
.01M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.56M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
10.79K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$-.04
|
$.05
|
$-.06
|
|
Diluted EPS
|
$-.04
|
$.05
|
$-.06
|
|
Revenue
|
$ 2.56M
|
$ .95M
|
$ .39M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -.46M
|
$ .55M
|
$ -.65M
|
|
Operating Income / Loss
|
$ -2.74M
|
$ -.7M
|
$ -.87M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ .84M
|
$ .32M
|
$ .69M
|
|
PE Ratio
|
|
|
|
| Splits |
|
May 09, 2022:
1:50
|
|
Oct 03, 2011:
1:100
|
|
Jul 27, 2009:
3:1
|
|
|
|
